Convenio de Suministro de Inhaladores por 12 Meses
Se requiere licitar el convenio de suministro de fármacos inhaladores para el abastecimiento de 12 meses. Se pide a los oferentes poner especial atención a lo estipulado en el punto 13 y 14 de las Bases Administrativas Adjuntas, ya que es primordial adju
14 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 5012-5899-SE14 | 09-07-2014 | Farmaceutica Caribean SpA | $3.830.610 |
| 5012-5968-SE14 | 09-07-2014 | Etex Farmaceutica Limitada | $2.975.000 |
| 5012-5895-SE14 | 03-07-2014 | Glaxosmithkline Chile Farmaceutica Limitada | $40.734.033 |
| 5012-5898-SE14 | 03-07-2014 | Etex Farmaceutica Limitada | $5.950.000 |
| 5012-5040-SE14 | 11-06-2014 | Glaxosmithkline Chile Farmaceutica Limitada | $4.527.831 |
| 5012-5242-SE14 | 09-06-2014 | Farmaceutica Caribean SpA | $7.196.489 |
| 5012-5241-SE14 | 09-06-2014 | Glaxosmithkline Chile Farmaceutica Limitada | $22.625.898 |
| 5012-5243-SE14 | 09-06-2014 | Etex Farmaceutica Limitada | $6.961.500 |
| 5012-3929-SE14 | 19-05-2014 | Farmaceutica Caribean SpA | $1.363.143 |
| 5012-4375-SE14 | 07-05-2014 | Etex Farmaceutica Limitada | $416.500 |
| 5012-4127-SE14 | 07-05-2014 | Glaxosmithkline Chile Farmaceutica Limitada | $2.784.600 |
| 5012-3185-SE14 | 05-05-2014 | Glaxosmithkline Chile Farmaceutica Limitada | $16.929.166 |
| 5012-3928-SE14 | 02-05-2014 | Glaxosmithkline Chile Farmaceutica Limitada | $19.238.837 |
| 5012-3930-SE14 | 23-04-2014 | Etex Farmaceutica Limitada | $2.856.000 |
| 5012-3180-SE14 | 11-04-2014 | Etex Farmaceutica Limitada | $535.500 |
| 5012-3181-SE14 | 10-04-2014 | Farmaceutica Caribean SpA | $1.098.108 |
| 5012-3134-SE14 | 28-03-2014 | Glaxosmithkline Chile Farmaceutica Limitada | $12.248.367 |
| 5012-2595-SE14 | 14-03-2014 | Farmaceutica Caribean SpA | $1.098.108 |
| 5012-2593-SE14 | 14-03-2014 | Etex Farmaceutica Limitada | $297.500 |
| 5012-2530-SE14 | 12-03-2014 | Glaxosmithkline Chile Farmaceutica Limitada | $2.948.760 |
| 5012-1330-SE14 | 12-02-2014 | Glaxosmithkline Chile Farmaceutica Limitada | $13.739.546 |
| 5012-348-SE14 | 13-01-2014 | Etex Farmaceutica Limitada | $2.499.000 |
| 5012-347-SE14 | 13-01-2014 | Glaxosmithkline Chile Farmaceutica Limitada | $15.405.205 |
| 5012-12852-SE13 | 06-12-2013 | Glaxosmithkline Chile Farmaceutica Limitada | $14.700.903 |
| 5012-12853-SE13 | 06-12-2013 | Salles Zapata y Compania Limitada | $297.500 |
| 5012-12383-SE13 | 18-11-2013 | Etex Farmaceutica Limitada | $357.000 |
| 5012-12394-SE13 | 18-11-2013 | Salles Zapata y Compania Limitada | $999.600 |
| 5012-12025-SE13 | 13-11-2013 | Glaxosmithkline Chile Farmaceutica Limitada | $15.385.498 |
| 5012-12024-SE13 | 13-11-2013 | Laboratorios Recalcine S.A. | $452.200 |
| 5012-12027-SE13 | 13-11-2013 | Salles Zapata y Compania Limitada | $297.500 |
| 5012-10887-SE13 | 11-10-2013 | Glaxosmithkline Chile Farmaceutica Limitada | $10.355.559 |
| 5012-10883-SE13 | 11-10-2013 | Farmaceutica Caribean SpA | $1.532.244 |
| 5012-11046-SE13 | 11-10-2013 | Etex Farmaceutica Limitada | $357.000 |
| 5012-10961-SE13 | 11-10-2013 | Salles Zapata y Compania Limitada | $446.250 |
| 5012-10154-SE13 | 10-09-2013 | Salles Zapata y Compania Limitada | $2.049.180 |
| 5012-10019-SE13 | 09-09-2013 | Glaxosmithkline Chile Farmaceutica Limitada | $6.030.337 |
| 5012-9939-SE13 | 06-09-2013 | Salles Zapata y Compania Limitada | $297.500 |
| 5012-9940-SE13 | 06-09-2013 | Etex Farmaceutica Limitada | $2.737.000 |
| 5012-9941-SE13 | 06-09-2013 | Farmaceutica Caribean SpA | $1.532.244 |
| 5012-9942-SE13 | 06-09-2013 | Glaxosmithkline Chile Farmaceutica Limitada | $17.258.689 |
| 5012-9938-SE13 | 06-09-2013 | Laboratorios Recalcine S.A. | $474.810 |
| 5012-8565-SE13 | 14-08-2013 | Etex Farmaceutica Limitada | $7.140 |
| 5012-9132-SE13 | 14-08-2013 | Farmaceutica Caribean SpA | $2.373.455 |
| 5012-9131-SE13 | 14-08-2013 | Laboratorios Recalcine S.A. | $1.130.500 |
| 5012-9130-SE13 | 14-08-2013 | Salles Zapata y Compania Limitada | $297.500 |
| 5012-9129-SE13 | 14-08-2013 | Glaxosmithkline Chile Farmaceutica Limitada | $16.825.113 |
| 5012-9128-SE13 | 14-08-2013 | Etex Farmaceutica Limitada | $2.737.000 |
| 5012-8566-SE13 | 14-08-2013 | Glaxosmithkline Chile Farmaceutica Limitada | $39.620 |
| 5012-8200-SE13 | 15-07-2013 | Farmaceutica Caribean SpA | $3.201.100 |
| 5012-8199-SE13 | 11-07-2013 | Etex Farmaceutica Limitada | $2.737.000 |
| 5012-8197-SE13 | 11-07-2013 | Glaxosmithkline Chile Farmaceutica Limitada | $16.252.532 |
| 5012-8198-SE13 | 11-07-2013 | Salles Zapata y Compania Limitada | $297.500 |
| 5012-8214-SE13 | 11-07-2013 | Glaxosmithkline Chile Farmaceutica Limitada | $4.938.195 |
| 5012-8201-SE13 | 11-07-2013 | Laboratorios Recalcine S.A. | $1.130.500 |
Fuente original:ficha mercadopublico.cl
